Continuous-wave Infrared Subsurface Optical Stimulation of the Rat Prostate Cavernous Nerves Using a 1490-nm Diode Laser - 27/09/13
, Charlotte D. Stahl a, Thomas C. Hutchens a, Gwen A. Lagoda c, Arthur L. Burnett c, Nathaniel M. Fried a, cAbstract |
Objective |
To optimize the infrared laser wavelength and optical nerve stimulation (ONS) parameters for both deep and rapid subsurface cavernous nerve (CN) stimulation in a rat model, in vivo.
Materials and Methods |
A 150-mW, 1490-nm diode laser providing an optical penetration depth (OPD) of 518 μm in water was operated in continuous-wave mode during stimulation of the CNs in 8 rats for 15 seconds irradiation time through a custom-built, single-mode fiber optic probe capable of producing a collimated, 1-mm diameter laser beam. Successful ONS was judged by an intracavernous pressure response in the rat penis. Subsurface ONS at 1490 nm was also compared with previous studies using 1455 nm and 1550 nm near-infrared diode laser wavelengths.
Results |
Subsurface ONS of the rat CN was successful through fascia layers with a thickness up to 380 μm using an incident laser power of ∼50 mW. Intracavernous pressure response times as short as 4.6 ± 0.2 seconds were recorded using higher laser powers below the nerve damage threshold.
Conclusion |
The 1490-nm diode laser represents a compact, low cost, high power, and high quality infrared light source for use in ONS. This wavelength provides deeper penetration than 1455-nm diode laser and more rapid and efficient nerve stimulation than 1550-nm diode laser.
Le texte complet de cet article est disponible en PDF.Plan
| Financial Disclosure: The authors declare that they have no relevant financial interests. |
|
| Funding Support: This research was supported in part by the U.S. Department of Defense Prostate Cancer Research Program (Grant# PC073709) and the U.S. Department of Energy (Grant# DE-FG02-06CH11460). Serhat Tozburun was supported in part by an Optics and Photonics Scholarship from SPIE. |
Vol 82 - N° 4
P. 969-973 - octobre 2013 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
